ArticleG3 (Bethesda, Md.)2026
MOKA: a pipeline for multiomics bridged SNP-set kernel association test.
Article in G3 (Bethesda, Md.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The explosion of genomic and multiomics data has created a need for scalable, reproducible tools that integrate functional annotations into genome-wide association studies (GWAS). We introduce the multiomics data bridged Kernel Association test (MOKA) pipeline, a Snakemake-based workflow that automates SNP-set kernel-based association testing by incorporating multiomics data, including gene expression, transcription factor binding, evolutionary conservation scores, and neural network-derived features. This data-bridged architecture enhances variant prioritization and aggregation, improving statistical power in GWAS. MOKA supports population structure correction via spectral decomposition, parallel computation, and post-GWAS analyses, including visualization, Gene Ontology annotation, pathway enrichment, and validation. As a use case, we applied MOKA to a schizophrenia GWAS cohort, identified 89 Bonferroni-significant genes, with a 15.7% validation rate in the disease-specific DisGeNET database and enrichment in pathways relevant to neuropsychiatric disease. MOKA provides a robust, scalable, and extensible framework for functional multiomics integration in genetic studies. It is open-source and available at https://github.com/davidenoma/moka.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.